GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Weiguang Biological Products Co Ltd (SZSE:002880) » Definitions » ROCE %

Shenzhen Weiguang Biological Products Co (SZSE:002880) ROCE % : 9.02% (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Weiguang Biological Products Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shenzhen Weiguang Biological Products Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 9.02%.


Shenzhen Weiguang Biological Products Co ROCE % Historical Data

The historical data trend for Shenzhen Weiguang Biological Products Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Weiguang Biological Products Co ROCE % Chart

Shenzhen Weiguang Biological Products Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.04 13.97 13.92 6.66 10.48

Shenzhen Weiguang Biological Products Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.43 10.57 10.29 11.41 9.02

Shenzhen Weiguang Biological Products Co ROCE % Calculation

Shenzhen Weiguang Biological Products Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=259.791/( ( (2575.954 - 229.756) + (2876.779 - 265.989) )/ 2 )
=259.791/( (2346.198+2610.79)/ 2 )
=259.791/2478.494
=10.48 %

Shenzhen Weiguang Biological Products Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=239.696/( ( (2876.779 - 265.989) + (3033.262 - 328.854) )/ 2 )
=239.696/( ( 2610.79 + 2704.408 )/ 2 )
=239.696/2657.599
=9.02 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Weiguang Biological Products Co  (SZSE:002880) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Shenzhen Weiguang Biological Products Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shenzhen Weiguang Biological Products Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Weiguang Biological Products Co (SZSE:002880) Business Description

Traded in Other Exchanges
N/A
Address
Guangming Street, No. 3402, Guangqiao Avenue, Guangming New District, Guangdong Province, Guangming, CHN, 518107
Shenzhen Weiguang Biological Products Co Ltd is the pharmaceutical company. It is mainly engaged in the research and development, production and sales of blood products. The company's products portfolio includes human albumin, intravenous immunoglobulin (pH4), lyophilized human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies immunoglobulin, tetanus Human immunoglobulin, histamine human immunoglobulin, human fibrinogen, a total of 21 varieties of 21 specifications.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Headlines

No Headlines